{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:20:08Z","timestamp":1791580808168,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":4811,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1017\/s1041610211000354","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T12:50:45Z","timestamp":1317214245000},"page":"1376-1385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease"],"prefix":"10.1016","volume":"23","author":[{"given":"David","family":"Darby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brodtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Budge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610211000354_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3956(00)00042-X","article-title":"Adding subjects or adding measurements: which increases the precision of longitudinal research","volume":"34","author":"Arndt","year":"2000","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610211000354_bb0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-3956(99)00044-8","article-title":"Charting patients\u2019 course: a comparison of statistics used to summarize patient course in longitudinal and repeated measures studies","volume":"34","author":"Arndt","year":"2000","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610211000354_bb0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/ALN.0b013e3181bc9719","article-title":"Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness","volume":"111","author":"Avidan","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1017\/S1041610211000354_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WAD.0b013e31816c92bf","article-title":"Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B","volume":"22","author":"Butters","year":"2008","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610211000354_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1037\/0882-7974.14.3.365","article-title":"An analysis of diversity in the cognitive performance of elderly community dwellers: individual differences in change scores as a function of age","volume":"14","author":"Christensen","year":"1999","journal-title":"Psychology and Aging"},{"key":"10.1017\/S1041610211000354_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/0894-4105.19.3.309","article-title":"Within-occasion intraindividual variability and preclinical diagnostic status: is intraindividual variability an indicator of mild cognitive impairment","volume":"19","author":"Christensen","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1017\/S1041610211000354_bb0040","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.56.11.1533","article-title":"Memory decline in healthy older people: implications for identifying mild cognitive impairment","volume":"56","author":"Collie","year":"2001","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00042752-200301000-00006","article-title":"CogSport: reliability and correlation with conventional cognitive tests used in post-concussion medical examinations","volume":"13","author":"Collie","year":"2003","journal-title":"Clinical Journal of Sport Medicine"},{"key":"10.1017\/S1041610211000354_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cct.2006.10.010","article-title":"Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study","volume":"28","author":"Collie","year":"2007","journal-title":"Contemporary Clinical Trials"},{"key":"10.1017\/S1041610211000354_bb0055","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archneurol.2010.189","article-title":"Plasma \u03b2-amyloid and cognitive decline","volume":"67","author":"Cosentino","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000354_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jalz.2008.12.003","article-title":"Defining and labeling disease-modifying treatments for Alzheimer's disease","volume":"5","author":"Cummings","year":"2009","journal-title":"Alzheimers Dementia"},{"key":"10.1017\/S1041610211000354_bb0065","series-title":"Walsh's Neuropsychology: A Clinical Approach.","author":"Darby","year":"2005"},{"key":"10.1017\/S1041610211000354_bb0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.59.7.1042","article-title":"Mild cognitive impairment can be detected by multiple assessments in a single day","volume":"59","author":"Darby","year":"2002","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1017\/S0033291703008031","article-title":"Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease","volume":"33","author":"De Jager","year":"2003","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610211000354_bb0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archneurol.2010.179","article-title":"Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people","volume":"67","author":"De Meyer","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000354_bb0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1602\/neurorx.2.2.348","article-title":"Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease","volume":"2","author":"Dickerson","year":"2005","journal-title":"NeuroRx"},{"key":"10.1017\/S1041610211000354_bb0090","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0095","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000354_bb0100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000354_bb0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(99)02355-7","article-title":"Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease","volume":"354","author":"Esiri","year":"1999","journal-title":"Lancet"},{"key":"10.1017\/S1041610211000354_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2869.2003.00363.x","article-title":"Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%","volume":"12","author":"Falleti","year":"2003","journal-title":"Journal of Sleep Research"},{"key":"10.1017\/S1041610211000354_bb0115","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/13803390500205718","article-title":"Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals","volume":"28","author":"Falleti","year":"2006","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1017\/S1041610211000354_bb0120","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/01.wad.0000213870.40300.21","article-title":"ADCS Prevention Instrument Project: overview and initial results","volume":"20","author":"Ferris","year":"2006","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610211000354_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000264823","article-title":"Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies","volume":"34","author":"Fredrickson","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1017\/S1041610211000354_bb0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(09)70145-0","article-title":"Will CSF analysis become routine in people with memory complaints","volume":"8","author":"Gauthier","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000354_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.31887\/DCNS.2009.11.2\/hhampel","article-title":"Biological markers for early detection and pharmacological treatment of Alzheimer's disease","volume":"11","author":"Hampel","year":"2009","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1017\/S1041610211000354_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.300.7.823","article-title":"Within-person across-neuropsychological test variability and incident dementia","volume":"300","author":"Holtzer","year":"2008","journal-title":"JAMA"},{"key":"10.1017\/S1041610211000354_bb0145","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jalz.2009.01.021","article-title":"A roadmap for the prevention of dementia. II: Leon Thal Symposium 2008","volume":"5","author":"Khachaturian","year":"2009","journal-title":"Alzheimers Dementia"},{"key":"10.1017\/S1041610211000354_bb0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jalz.2009.03.002","article-title":"Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions","volume":"5","author":"Kokjohn","year":"2009","journal-title":"Alzheimers Dementia"},{"key":"10.1017\/S1041610211000354_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0074-7742(09)00408-5","article-title":"The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview","volume":"84","author":"Luque","year":"2009","journal-title":"International Review of Neurobiology"},{"key":"10.1017\/S1041610211000354_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/arclin\/acp010","article-title":"Validity of the CogState computerized cognitive test battery: sensitivity to mild traumatic brain injury, mild cognitive impairment, schizophrenia and AIDS dementia complex","volume":"24","author":"Maruff","year":"2008","journal-title":"Archives of Clinical Neuropsychology"},{"key":"10.1017\/S1041610211000354_bb0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000080229","article-title":"Subtle memory decline over 12 months in mild cognitive impairment","volume":"18","author":"Maruff","year":"2004","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610211000354_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1749-6632.2009.04944.x","article-title":"CSF biomarkers: pinpointing Alzheimer pathogenesis","volume":"1180","author":"Mattsson","year":"2009","journal-title":"Annals of the New York Academy of Science"},{"key":"10.1017\/S1041610211000354_bb0180","first-page":"163","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiological Disorders"},{"key":"10.1017\/S1041610211000354_bb0185","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneurol.2009.201","article-title":"Promising strategies for the prevention of dementia","volume":"66","author":"Middleton","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000354_bb0190","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000354_bb0195","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.aje.a009893","article-title":"Methodological issues in the study of cognitive decline","volume":"149","author":"Morris","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1017\/S1041610211000354_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/REVNEURO.2009.20.1.1","article-title":"Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid","volume":"20","author":"Nimmrich","year":"2009","journal-title":"Review of Neuroscience"},{"key":"10.1017\/S1041610211000354_bb0205","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.42.2.396","article-title":"Memory function in normal aging","volume":"42","author":"Petersen","year":"1992","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0210","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1017\/S1041610211000354_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1017\/S1041610211000354_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-7-7","article-title":"Recent developments in Alzheimer's disease therapeutics","volume":"7","author":"Rafii","year":"2009","journal-title":"BMC Medicine"},{"key":"10.1017\/S1041610211000354_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/bmm.09.91","article-title":"Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible","volume":"4","author":"Reiman","year":"2010","journal-title":"Biomarkers in Medicine"},{"key":"10.1017\/S1041610211000354_bb0230","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0235","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0240","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neurobiolaging.2008.09.023","article-title":"When does age-related cognitive decline begin","volume":"30","author":"Salthouse","year":"2009","journal-title":"Neurobiological Aging"},{"key":"10.1017\/S1041610211000354_bb0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1017\/S1041610211000354_bb0250","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jalz.2009.07.038","article-title":"Current Alzheimer's disease clinical trials: methods and placebo outcomes","volume":"5","author":"Schneider","year":"2009","journal-title":"Alzheimers Dementia"},{"key":"10.1017\/S1041610211000354_bb0255","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"10.1017\/S1041610211000354_bb0260","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1213\/01.ane.0000263285.03361.3a","article-title":"Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery","volume":"104","author":"Silbert","year":"2007","journal-title":"Anesthesia and Analgesia"},{"key":"10.1017\/S1041610211000354_bb0265","first-page":"213","article-title":"Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease","volume":"33","author":"Spires-Jones","year":"2009","journal-title":"Neurobiological Disorders"},{"key":"10.1017\/S1041610211000354_bb0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wad.0000191420.61260.a8","article-title":"The role of biomarkers in clinical trials for Alzheimer disease","volume":"20","author":"Thal","year":"2006","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610211000354_bb0275","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","article-title":"Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease","volume":"46","author":"Villemagne","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1017\/S1041610211000354_bb0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bandc.2005.10.004","article-title":"Mild memory impairment in healthy older adults is distinct from normal aging","volume":"60","author":"Weaver Cargin","year":"2006","journal-title":"Brain Cognition"},{"key":"10.1017\/S1041610211000354_bb0285","first-page":"15","article-title":"Successful cognitive aging: individual differences among physicians on a computerized test of mental state","volume":"28","author":"Weintraub","year":"1994","journal-title":"Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610211000354_bb0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1212\/01.wnl.0000341782.71418.6c","article-title":"Educational attainment and cognitive decline in old age","volume":"72","author":"Wilson","year":"2009","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000354_bb0295","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.0b013e3181a92c36","article-title":"Predictors of maintaining cognitive function in older adults: the Health ABC study","volume":"72","author":"Yaffe","year":"2009","journal-title":"Neurology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022402163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022402163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610211000354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T16:23:01Z","timestamp":1735834981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104161022402163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S104161022402163X"],"URL":"https:\/\/doi.org\/10.1017\/s1041610211000354","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610211000354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Copyright \u00a9 International Psychogeriatric Association 2011. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}